We are thrilled to welcome Resistell as part of our first cohort of start-ups. Resistell is a deep-tech start-up addressing the problem of excessive time to results in Antimicrobial Susceptibility Testing (AST). Antimicrobial Resistance (AMR) is one of the biggest global health challenges.
We are thrilled to welcome TOLREMO therapeutic as part of our first cohort of start-ups. TOLREMO therapeutics AG is an ETH spin- off based on cutting-edge science and guided by pioneering real-world medicine. They have created a broad cancer drug resistance platform that provides a unique entry point into a major clinical problem.
We are thrilled to welcome Inura as part of our first cohort of start-ups. Inura Medical AG is a Swiss start-up with a clear vision to make a difference in women’s health. Inura is developing an innovative, first-of-its kind “intraurethral ovulum” that utilizes a novel route of drug administration to treat diseases of the bladder and lower urinary tract.
We are thrilled to welcome Hi-D Imaging as part of our first cohort of start-ups. Hi-D Imaging is an ETH Spinoff MedTech start-up company that aims to revolutionize the medical image processing for cardiovascular operation
We are thrilled to welcome Sleepiz as part of our first cohort of start-ups. Sleepiz AG is an ETH Spin-off leveraging the power of sleep insights with a device that is simply placed next to the bed.
We are thrilled to welcome Aspivix as part of our first cohort of start-ups . Aspivix is a MedTech start-up, founded in 2015, which focuses on Women’s Healthcare. They are developing modern, simple, and gentle solutions for gynecology.